v3.25.2
Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash Flows from operating activities:        
Net loss $ 1,995,694 $ 196,709 $ (3,753,268) $ (6,610,119)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation expense 407 193,497
Common stock issued for services     5,561,500 7,272,000
Changes in operating assets and liabilities:        
Accounts receivable (1,959,417) 941,425 (3,019,965) (819,862)
Other current assets     1,136
Deferred revenue (150,000) (150,000) 150,000
Deferred financing costs (7,000)    
Accounts payable and accrued expenses 99,500 111,933 215,934 374,921
Accounts payable - related party (68,209) (68,209) (137,771)
Accrued interest 7,268 13,250
Accounts payable settled with common stock     156,000
OID (26,910) (60,001)
Net Cash used in operating activities 109,542 1,031,858 (1,104,759) 423,802
Cash flow from investing activities:        
Fixed asset, net (3,230) (6,498)
Net Cash Provided by Investing Activities (3,230) (6,498)
Net Cash provided by financing activities:        
Funds from notes 133,910    
Common stock issued for cash     10,201
Notes payable     400,000
Note settlement     315,104
Net Cash Provided by financing activities 133,910 715,104 10,201
Net change in Cash and cash equivalents for the year 240,222 1,031,858 (396,153) 434,003
Cash and cash equivalents at the beginning of the year 76,356 472,509 472,509 38,506
Cash and cash equivalents at the end of the year $ 316,578 $ 1,504,367 76,356 472,509
Non-cash investing and financing activities:        
Common stock issued for note settlement     315,104
Common stock issued for payable     $ 156,000